title: Current management of colorectal metastases to lung.
abstract: Colorectal carcinoma is the second most common visceral cancer in the United States, in both incidence and fatality rate. Of patients with colorectal carcinoma, 45% undergo resection and are cured. In cases of recurrence, 2% are restricted to lung only. A select group of 287 patients over 30 years at Memorial Sloan-Kettering Cancer Center underwent a surgical approach, which produced a survival rate of 40% at 5 years and 32% at 10 years.
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors.forename: P M
authors.initials: PM
authors.lastname: McCormack
authors.forename: R J
authors.initials: RJ
authors.lastname: Ginsberg
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary / Q000601:surgery; D001984:Bronchial Neoplasms / Q000556:secondary / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000556:secondary* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000601:surgery; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D008175:Lung Neoplasms / Q000556:secondary* / Q000601:surgery; D018579:Patient Selection; D011013:Pneumonectomy; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D014481:United States
chemical_list: D002272:Carcinoembryonic Antigen